AngioScore Signs Distribution Agreement with USCI Japan For the AngioSculpt Balloon Catheter.ALAMEDA, Calif. -- AngioScore Inc. and USCI USCI United States Colored Infantry USCI University College Sedaya International USCI United States Computers, Incorporated Japan Ltd. announced today that the companies have entered into a definitive distribution agreement for AngioScore's AngioSculpt Balloon Catheter balloon catheter n. A catheter with an inflatable balloon at its tip, used especially to expand a partially obstructed blood vessel or bodily passage and to measure blood pressure in a blood vessel. Also called balloon-tip catheter. . This agreement provides USCI Japan Ltd. with exclusive rights to distribute the AngioSculpt in Japan for all coronary applications. USCI Japan Ltd. will be responsible for all registration activities for the AngioSculpt in Japan. In a separate transaction, USCI Japan made a $1.5 million equity investment in AngioScore Inc. USCI Japan Ltd. is one of the premier medical device distribution organizations in Japan and provides AngioScore with an outstanding launch platform for the AngioSculpt once all the appropriate regulatory approvals have been obtained. "We are extremely pleased to have entered into this key strategic partnership," said Thomas R. Trotter, AngioScore's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We look forward to working together with USCI Japan to assure the successful launch of the AngioSculpt in Japan." Michael D. Van Zandt Van Zandt, a surname, may refer to: People
About AngioScore AngioScore Inc. (www.angioscore.com) is an endovascular therapy company located in Alameda. The company's first product is the AngioSculpt Scoring Balloon Catheter. AngioSculpt is an investigational device in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . AngioScore can be contacted at 510-263-0480 or info@angioscore.com. About USCI Japan USCI Japan Ltd. (www.usci.co.jp) is an interventional vascular company with headquarters in Tokyo. USCI Japan is partnered with MC, MedCare and Medtronic in servicing physicians and patients with best-in-class interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based , cardiac rhythm management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. and cardiac surgery products throughout Japan. USCI Japan can be contacted at +81-3-3578-7780. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion